+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Companion Animal Vaccine Market by Animal Type (Cats, Dogs), Vaccine Type (Inactivated, Live Attenuated, mRNA), Route Of Administration, Distribution Channel - Global Forecast 2025-2030- Product Image
Companion Animal Vaccine Market by Animal Type (Cats, Dogs), Vaccine Type (Inactivated, Live Attenuated, mRNA), Route Of Administration, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Companion Animal Vaccine Market by Animal Type (Cats, Dogs), Vaccine Type (Inactivated, Live Attenuated, mRNA), Route Of Administration, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674687
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The companion animal vaccine market is undergoing rapid transformation as technological advancements, evolving policies, and shifting consumer needs redefine how pet immunization is delivered and managed. Executive awareness and strategic agility are now paramount for organizations aiming to thrive in this dynamic landscape.

Market Snapshot: Companion Animal Vaccine Market Outlook

The Companion Animal Vaccine Market grew from USD 4.97 billion in 2024 to USD 5.39 billion in 2025. It is expected to continue growing at a CAGR of 8.26%, reaching USD 8.01 billion by 2030.

Scope & Segmentation

  • Animal Type: Includes both cats and dogs, each requiring distinct vaccine portfolios and immunization strategies.
  • Vaccine Type: Covers inactivated (split cell, whole cell), live attenuated, mRNA, recombinant, subunit, and toxoid technologies to address diverse immunological demands.
  • Route of Administration: Range extends from mucosal (nasal, oral) to parenteral (intramuscular, subcutaneous) methods, allowing market stakeholders to match products with delivery best suited to patient, practitioner, and workflow preferences.
  • Distribution Channel: Encompasses online e-pharmacies, manufacturer websites, traditional pharmacies, veterinary clinics, and veterinary hospitals to maximize reach and convenience.
  • Regional Coverage: Markets are analyzed across the Americas, Europe/Middle East/Africa, and Asia-Pacific, ensuring that region-specific trends, regulatory climate, and product performance are included for strategic evaluation.
  • Leading Companies: Global players assessed include Zoetis Inc., Merck & Co., Elanco Animal Health Incorporated, Boehringer Ingelheim, Ceva Santé Animale S.A., Virbac S.A., Vetoquinol S.A., Dechra Pharmaceuticals, Laboratorios Hipra, Animalcare Group, and Esco Healthcare.

Key Takeaways

  • Technological progress is accelerating the adoption of mRNA, recombinant, and next-generation platforms within the companion animal vaccine market, driving new opportunities for targeted immunization and optimized product development.
  • Consumer demand is shifting toward convenient, minimally invasive, and needle-free delivery options, prompting growth in nasal and oral vaccine formats that reduce animal handling stress and support compliance among pet owners.
  • Regulatory alignment and streamlined approval pathways are encouraging translational research and faster market entry for innovative vaccine types, particularly in major developed markets with rigorous but adaptable frameworks.
  • Channel diversification, including direct-to-customer digital supply channels, is strengthening reach to end-users while veterinary clinics and pharmacies remain reliable distribution touchpoints for professional administration and ongoing health management.

Tariff Impact: Navigating U.S. Tariff Adjustments in 2025

  • Recent U.S. tariff measures enacted in 2025 have increased costs for raw materials and finished products within the vaccine supply chain, prompting producers to shift toward domestic sourcing and closer supplier partnerships to maintain competitiveness.
  • Distributors and veterinary networks have reported incremental adjustments in end-pricing, but strategic supply chain mapping and nearshoring efforts have helped mitigate significant disruption to vaccine availability and cost volatility.
  • The complexity driven by layered tariffs has accelerated the need for transparent cost modeling, dynamic inventory management, and collaborative risk assessment among manufacturers, clinics, and industry consortia.

Methodology & Data Sources

Findings are grounded in structured interviews with veterinary KOLs, supply executives, and research scientists, as well as practitioner and procurement surveys for direct market feedback. Comprehensive secondary research, including review of regulatory filings, technical journals, trade records, and benchmarking studies, was conducted to ensure accuracy and cross-validation. Advanced analytics and peer review further strengthen the reliability of insights.

Why This Report Matters

  • Empowers senior decision-makers with actionable intelligence to inform investment, R&D, and go-to-market strategies in a complex, innovation-driven segment.
  • Provides clear segment and technology context relevant to operational scaling, partner identification, and competitive positioning across global and regional stakeholders.
  • Enables organizations to anticipate policy and trade risks, optimize supply planning, and capture growth by aligning portfolios with evolving customer expectations and regulatory environments.

Conclusion

The companion animal vaccine market is defined by technological change, regulatory adaptation, and evolving consumer priorities. Leaders who embrace agile strategies and data-driven planning are best positioned for sustained success in this growing industry.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of mRNA and next-generation vaccine platforms for dogs and cats
5.2. Increasing demand for combination vaccines targeting multiple canine diseases to improve coverage
5.3. Technological advancements in vaccine delivery systems such as needle-free injectors and patches
5.4. Regulatory harmonization and fast-track approvals enabling quicker market entry for novel pet vaccines
5.5. Growing emphasis on personalized vaccination schedules based on individual pet genetics and lifestyle factors
5.6. Expansion of probiotic and immunomodulator adjunct therapies to enhance vaccine efficacy in companion animals
5.7. Integration of digital health monitoring and telemedicine platforms to boost vaccine compliance rates
5.8. Rising concerns over vaccine-associated adverse events driving development of safer adjuvants and formulations
5.9. Strategic collaborations between biotech firms and veterinary clinics to accelerate vaccine R&D pipelines
5.10. Global expansion of veterinary clinic networks in emerging markets increasing access to animal vaccines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Companion Animal Vaccine Market, by Animal Type
8.1. Introduction
8.2. Cats
8.3. Dogs
9. Companion Animal Vaccine Market, by Vaccine Type
9.1. Introduction
9.2. Inactivated
9.2.1. Split Cell
9.2.2. Whole Cell
9.3. Live Attenuated
9.4. mRNA
9.5. Recombinant
9.6. Subunit
9.7. Toxoid
10. Companion Animal Vaccine Market, by Route Of Administration
10.1. Introduction
10.2. Mucosal
10.2.1. Nasal
10.2.2. Oral
10.3. Parenteral
10.3.1. Intramuscular
10.3.2. Subcutaneous
11. Companion Animal Vaccine Market, by Distribution Channel
11.1. Introduction
11.2. Online
11.2.1. E Pharmacies
11.2.2. Manufacturer Websites
11.3. Pharmacies
11.4. Veterinary Clinics
11.5. Veterinary Hospitals
12. Americas Companion Animal Vaccine Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Companion Animal Vaccine Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Companion Animal Vaccine Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc.
15.3.2. Merck & Co., Inc.
15.3.3. Elanco Animal Health Incorporated
15.3.4. Boehringer Ingelheim International GmbH
15.3.5. Ceva Santé Animale S.A.
15.3.6. Virbac S.A.
15.3.7. Vetoquinol S.A.
15.3.8. Dechra Pharmaceuticals PLC
15.3.9. Laboratorios Hipra, S.A.
15.3.10. Animalcare Group PLC
15.3.11. Esco Healthcare
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. COMPANION ANIMAL VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. COMPANION ANIMAL VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. COMPANION ANIMAL VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. COMPANION ANIMAL VACCINE MARKET: RESEARCHAI
FIGURE 24. COMPANION ANIMAL VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 25. COMPANION ANIMAL VACCINE MARKET: RESEARCHCONTACTS
FIGURE 26. COMPANION ANIMAL VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COMPANION ANIMAL VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY CATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DOGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SPLIT CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SPLIT CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY WHOLE CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY WHOLE CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBUNIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBUNIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY TOXOID, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY TOXOID, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY E PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY E PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COMPANION ANIMAL VACCINE MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES COMPANION ANIMAL VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 105. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 106. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 107. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 108. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 109. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 110. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 111. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 114. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 115. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 116. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 117. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 120. CANADA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 124. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 125. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 126. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 127. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 128. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 129. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 133. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 205. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 206. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 207. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 208. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 209. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 212. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 213. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 214. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 215. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 220. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 221. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 222. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 223. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 224. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 225. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 228. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 229. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 230. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 231. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 251. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 252. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 253. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 254. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 255. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 256. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 257. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 260. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 261. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 262. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 263. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 266. ITALY COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 267. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 268. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 269. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 270. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 271. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 272. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 273. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 274. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 275. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 276. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 277. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 278. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 279. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 282. SPAIN COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA COMPANION ANIMAL VACCINE MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY INACTIVATED, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA COMPANION ANIMAL VACCINE MARKET SIZE, BY MUCOSAL,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Companion Animal Vaccine market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Virbac S.A.
  • Vetoquinol S.A.
  • Dechra Pharmaceuticals PLC
  • Laboratorios Hipra, S.A.
  • Animalcare Group PLC
  • Esco Healthcare

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.39 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.01 Billion
Compound Annual Growth Rate8.2%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Veterinary Vaccines Market by Product Type (Inactivated Vaccines, Live Attenuated Vaccines, Subunit & Recombinant Vaccines), Animal Type (Companion Animals, Livestock Animals), Route Of Administration, Disease Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Veterinary Vaccines Market by Product Type (Inactivated Vaccines, Live Attenuated Vaccines, Subunit & Recombinant Vaccines), Animal Type (Companion Animals, Livestock Animals), Route Of Administration, Disease Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Veterinary/Animal Vaccines Market by Animal Type (Aquaculture, Cattle, Companion Animals), Vaccine Technology (Conjugate, Killed/Inactivated, Live Attenuated), Route Of Administration, Disease Type, End User - Global Forecast 2025-2030 - Product Image

Veterinary/Animal Vaccines Market by Animal Type (Aquaculture, Cattle, Companion Animals), Vaccine Technology (Conjugate, Killed/Inactivated, Live Attenuated), Route Of Administration, Disease Type, End User - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Companion Animal Vaccines Market Size, Share & Trends Analysis Report by Animal Type (Canine, Feline), Product, Route of Administration, Distribution Channel, Product, Region, with Growth Forecasts, 2025-2030 - Product Image

Companion Animal Vaccines Market Size, Share & Trends Analysis Report by Animal Type (Canine, Feline), Product, Route of Administration, Distribution Channel, Product, Region, with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Companion Animal Vaccines - Global Strategic Business Report - Product Image

Companion Animal Vaccines - Global Strategic Business Report

  • Report
  • 473 Pages
  • Global
From
Companion Animal Vaccines Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Companion Animal Vaccines Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 130 Pages
  • Global
From

About the Companion Animal Vaccine Market

Within the realm of animal healthcare and veterinary medicine, the Companion Animal Vaccine market is an essential segment focused on the immunization of pets, such as dogs, cats, and horses, against various infectious diseases. This sector addresses the preventative healthcare needs of companion animals by providing a variety of vaccines that target illnesses such as rabies, distemper, parvovirus, and feline leukemia, among others. The availability and development of these vaccines are driven by continuous scientific research, technological advancements, and an increasing awareness among pet owners about the importance of preventative care. Moreover, this market is influenced by regulatory frameworks and animal welfare organizations advocating for the health and safety of companion animals. The administration of vaccines is a critical component of routine veterinary care, aiming to ensure the longevity and quality of life of pets, whilst also aiding in the control of disease outbreaks that could potentially affect human populations as well. Prominent players in the companion animal vaccine market include Zoetis, Merck Animal Health (known as MSD Animal Health outside the United States and Canada), Boehringer Ingelheim, Elanco, Virbac, Vetoquinol, and Ceva Santé Animale. These companies are noteworthy for their extensive research and development efforts, comprehensive vaccine portfolios, and substantial contributions to veterinary medicine and overall animal health. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.